Zobrazeno 1 - 10
of 658
pro vyhledávání: '"Matthew T Roe"'
Autor:
Guillaume Marquis‐Gravel, Amanda Stebbins, Lisa M. Wruck, Matthew T. Roe, Mark B. Effron, Bradley G. Hammill, Jeff Whittle, Jeffrey J. VanWormer, Holly R. Robertson, Jacqueline D. Alikhaani, Sunil Kripalani, Peter M. Farrehi, Saket Girotra, Catherine P. Benziger, Tamar S. Polonsky, J. Greg Merritt, Kamal Gupta, Thomas E. McCormick, Kirk U. Knowlton, Sandeep K. Jain, Ajar Kochar, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, W. Schuyler Jones
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Background In patients with atherosclerotic cardiovascular disease, increasing age is concurrently associated with higher risks of ischemic and bleeding events. The objectives are to determine the impact of aspirin dose on clinical outcomes according
Externí odkaz:
https://doaj.org/article/094387e244204d1ea7d8c9c34e5dcd36
Autor:
Saket Girotra, Amanda Stebbins, Lisa Wruck, Guillaume Marquis‐Gravel, Kamal Gupta, Peter Farrehi, Catherine P. Benziger, Mark B. Effron, Jeffrey Whittle, Daniel Muñoz, Sunil Kripalani, R. David Anderson, Sandeep K. Jain, Tamar S. Polonsky, Faraz S. Ahmad, Matthew T. Roe, Russell L. Rothman, Robert A. Harrington, Adrian F. Hernandez, W. Schuyler Jones
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 20 (2023)
Background The ADAPTABLE (Aspirin Dosing: A Patient‐Centric Trial Assessing Benefits and Long‐Term Effectiveness) was a large, pragmatic, randomized controlled trial that found no difference between high‐ versus low‐dose aspirin for secondary
Externí odkaz:
https://doaj.org/article/91da8deb544f41d98ac20c29a09e6535
Autor:
Theresa M. Coles, Adrian F. Hernandez, Bryce B. Reeve, Karon Cook, Michael C. Edwards, Marc Boutin, Elizabeth Bush, Arnold Degboe, Lothar Roessig, Amy Rudolph, Pauline McNulty, Nikunj Patel, Trish Kay-Mugford, Margaret Vernon, Michael Woloschak, Gustavo Buchele, John A. Spertus, Matthew T. Roe, Denise Bury, Kevin Weinfurt
Publikováno v:
Health and Quality of Life Outcomes, Vol 19, Iss 1, Pp 1-7 (2021)
Abstract Objectives There has been limited success in achieving integration of patient-reported outcomes (PROs) in clinical trials. We describe how stakeholders envision a solution to this challenge. Methods Stakeholders from academia, industry, non-
Externí odkaz:
https://doaj.org/article/01205d55742840b0a35ea3cc90285894
Autor:
Christopher B. Fordyce, Robert P. Giugliano, Christopher P. Cannon, Matthew T. Roe, Abhinav Sharma, Courtney Page, Jennifer A. White, Yuliya Lokhnygina, Eugene Braunwald, Michael A. Blazing
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Unlike patients with low ejection fraction after an acute coronary syndrome (ACS), little is known about the long‐term incidence and influence of cardiovascular events before sudden death among stabilized patients after ACS. Methods and
Externí odkaz:
https://doaj.org/article/2daeb05042684ef589f10e4b38d93ba2
Autor:
Chiara Melloni, MD, MHS, Susan F. Slovin, MD, PhD, Allan Blemings, MS, Shaun G. Goodman, MD, MSc, Christopher P. Evans, MD, Jan Nilsson, MD, Deepak L. Bhatt, MD, MPH, Konstantin Zubovskiy, MD, Tine K. Olesen, MS, MBA, Klaus Dugi, MD, Noel W. Clarke, MBBS, ChM, Celestia S. Higano, MD, Matthew T. Roe, MD, MHS
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 1, Pp 70-81 (2020)
Objectives: This study will compare the incidence of major adverse cardiovascular events (MACEs) with androgen deprivation therapy (ADT) among men with advanced prostate cancer who are being treated with a gonadotropin-releasing hormone (GnRH) antago
Externí odkaz:
https://doaj.org/article/dfc10cb0c1f24371b8b3b6de0c4a2d51
Autor:
Muhammad Shahzeb Khan, Muhammad Shariq Usman, Khawaja M Talha, Harriette G C Van Spall, Stephen J Greene, Muthiah Vaduganathan, Sadiya S Khan, Nicholas L Mills, Ziad A Ali, Robert J Mentz, Gregg C Fonarow, Sunil V Rao, John A Spertus, Matthew T Roe, Stefan D Anker, Stefan K James, Javed Butler, Darren K McGuire
Publikováno v:
European Heart Journal. 44:1890-1909
Conventional randomized controlled trials (RCTs) can be expensive, time intensive, and complex to conduct. Trial recruitment, participation, and data collection can burden participants and research personnel. In the past two decades, there have been
Autor:
Michel Zeitouni, Robert M. Clare, Karen Chiswell, Jawan Abdulrahim, Nishant Shah, Neha P. Pagidipati, Svati H. Shah, Matthew T. Roe, Manesh R. Patel, W. Schuyler Jones
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 24 (2020)
Background Coronary artery disease (CAD) is increasing among young adults. We aimed to describe the cardiovascular risk factors and long‐term prognosis of premature CAD. Methods and Results Using the Duke Databank for Cardiovascular Disease, we eva
Externí odkaz:
https://doaj.org/article/ad505049e765497686d1bca67ef989fd
Autor:
Carrie B. Dombeck, Terri Hinkley, Christopher B. Fordyce, Katelyn Blanchard, Matthew T. Roe, Amy Corneli
Publikováno v:
Contemporary Clinical Trials Communications, Vol 17, Iss , Pp - (2020)
Background/Aims: Numerous reasons have been identified for why U.S.-based principal investigators choose to not continue participating in FDA-regulated trials. However, unexplored are reasons why a substantial number of principal investigators, facin
Externí odkaz:
https://doaj.org/article/1fc5376d8c2e4c298a48cda50e46f830
Autor:
Christopher B. Fordyce, Kaitlin Malone, Annemarie Forrest, Terri Hinkley, Amy Corneli, James Topping, Matthew T. Roe
Publikováno v:
Contemporary Clinical Trials Communications, Vol 16, Iss , Pp - (2019)
The Clinical Trials Transformation Initiative (CTTI) Strengthening the Investigator Community Project was prompted by the need to understand the reasons for high rates of turnover among investigators who lead US Food and Administration-regulated clin
Externí odkaz:
https://doaj.org/article/468a8f65c18d42999373494caa5608c8
Autor:
Amy Corneli, PhD, MPH, Christine Pierre, RN, Terri Hinkley, RN, BScN, MBA, CCRC, Li Lin, MS, Christopher B. Fordyce, MD, MSc, Gerrit Hamre, MA, Matthew T. Roe, MD, MHS
Publikováno v:
Contemporary Clinical Trials Communications, Vol 6, Iss C, Pp 31-38 (2017)
Concerns have been raised over the high turnover rate for clinical investigators. Using the U.S. Food and Drug Administration's (FDA) Bioresearch Monitoring Information System database, we conducted an online survey to identify factors that affect pr
Externí odkaz:
https://doaj.org/article/2b72abf138d94bdfaf24fb33bb80b090